CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 22 enrolled
Drug / intervention
Glucose +2 moreother
Likely dose
Not stated in record
Key inclusion· 7
  • Hemoglobin A1c 5.7–6.4% (prediabetic range)
  • Not a dietary supplement user
  • No medications affecting vasodilation, inflammation, or energy metabolism
  • No prior cardiovascular disease
Key exclusion· 4
  • Unstable weight (fluctuation ≥2 kg)
  • Vegetarian or history of dairy allergy
  • Heavy alcohol use (>3 drinks/day or >10 drinks/week)
  • Regular aerobic exercise ≥7 hours/week

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02482610
NCT02482610N/ACompleted

Regulation of Postprandial Nitric Oxide Bioavailability and Vascular Function By Dairy Fat

Ohio State University·interventional·Posted Jun 26, 2015·Updated Apr 29, 2019

In Brief

A clinical study evaluating Glucose, Glucose with Whole Fat Milk, and 1 other intervention for Prediabetes. Completed, enrolled 22 participants across 1 site.

Detailed Summary

Cardiovascular disease (CVD) is the leading cause of death in the United States. Short-term increases in blood sugar, or postprandial hyperglycemia (PPH), affect blood vessel function and increase the risk of CVD. Greater intakes of dairy foods have been associated with a lower risk of CVD, but whether these effects occur directly or indirectly by displacing foods in the diet that might increase CVD risk is unclear. Further controversial is the extent to which dietary fat derived from dairy foods regulate the risk of CVD. The health benefits of dairy on CVD risk are at least partly attributed to its ability to limit PPH and resulting PPH-mediated responses leading to vascular dysfunction. This provides rationale to investigate full-fat containing dairy as a dietary strategy to reduce PPH and risk for heart disease. The objective of this project is to define the extent to which full-fat dairy milk compared to non-fat dairy milk protects against PPH-induced vascular dysfunction by reducing oxidative stress responses that limit nitric oxide bioavailability to the vascular endothelium in adults with prediabetes.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsPrediabetes
CountriesUnited States
Collaborators--

Timeline

N/ACompletedFinished
20162017201820192020202120222023202420252026
First PostedJun 26, 2015
Enrollment StartJun 1, 2016
Primary CompletionApr 1, 2017
Study CompletionMar 1, 2018
TodayJul 2, 2026
Enrollment to primary: 10 monthsPosted 11.0 years ago

Interventions

Glucoseother

Following baseline measurements, participants will consume a 75 g glucose solution within five minutes.

Glucose with Whole Fat Milkother

Following baseline measurements, participants will consume 75 g glucose dissolved in two cups of whole fat milk within five minutes.

Glucose with Non-fat Milkother

Following baseline measurements, participants will consume 75 g glucose dissolved in two cups of non-fat milk within five minutes.